Karolinska Development AB (KDEVF)
0.2576
0.00 (0.00%)
USD |
OTCM |
Oct 28, 16:00
Karolinska Development Total Assets (Quarterly): 117.25M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 117.25M |
March 31, 2024 | 118.29M |
December 31, 2023 | 125.00M |
September 30, 2023 | 115.18M |
June 30, 2023 | 114.78M |
March 31, 2023 | 117.97M |
December 31, 2022 | 120.09M |
September 30, 2022 | 111.48M |
June 30, 2022 | 126.09M |
March 31, 2022 | 141.92M |
December 31, 2021 | 122.61M |
September 30, 2021 | 128.17M |
June 30, 2021 | 127.10M |
March 31, 2021 | 99.08M |
December 31, 2020 | 108.70M |
September 30, 2020 | 91.25M |
June 30, 2020 | 107.44M |
March 31, 2020 | 100.27M |
December 31, 2019 | 124.85M |
September 30, 2019 | 81.34M |
June 30, 2019 | 87.93M |
March 31, 2019 | 85.12M |
December 31, 2018 | 88.46M |
September 30, 2018 | 80.05M |
June 30, 2018 | 76.78M |
Date | Value |
---|---|
March 31, 2018 | 78.26M |
December 31, 2017 | 81.11M |
September 30, 2017 | 76.23M |
June 30, 2017 | 48.61M |
March 31, 2017 | 47.51M |
December 31, 2016 | 48.35M |
September 30, 2016 | 52.43M |
June 30, 2016 | 53.73M |
March 31, 2016 | 64.42M |
December 31, 2015 | 73.07M |
September 30, 2015 | 86.84M |
June 30, 2015 | 90.88M |
March 31, 2015 | 209.24M |
December 31, 2014 | 170.48M |
September 30, 2014 | 228.33M |
June 30, 2014 | 263.05M |
March 31, 2014 | 301.63M |
December 31, 2013 | 247.47M |
September 30, 2013 | 312.02M |
June 30, 2013 | 311.59M |
March 31, 2013 | 321.22M |
December 31, 2012 | 328.76M |
September 30, 2012 | 331.31M |
June 30, 2012 | 305.76M |
March 31, 2012 | 338.32M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
91.25M
Minimum
Sep 2020
141.92M
Maximum
Mar 2022
116.71M
Average
117.97M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
Abliva AB | 7.132M |
Calliditas Therapeutics AB | 164.63M |
Oncopeptides AB | 27.02M |
BioInvent International AB | 107.86M |
Hansa Biopharma AB | 93.30M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 1.264M |
Shareholders Equity (Quarterly) | 115.99M |
Current Ratio | 4.710 |